Metabolic Syndrome in Women: An Evidence-Based Review

Abstract

Background: Metabolic syndrome (MetS) is a group of metabolic abnormalities that significantly increase the risk of cardiovascular diseases (CVDs), Type 2 diabetes mellitus (T2DM), and pre-mature death. In women, risk of developing metabolic syndrome increases during the menopausal transition. This review aims to assess the impact of MetS in middle aged women, especially during the transition period.

Methods: This review was conducted using a full search strategy of potentially relevant literatures on MetS across all included database. The collected data were organized, summarized, and presented in a logical, descriptive manner.

Results: The synthesized evidence indicates an increased prevalence of MetS among women undergoing the menopausal transition. 

Conclusion: Increased prevalence of MetS among menopausal women is signaling an elevated risk of cardiovascular diseases, Type 2 diabetes mellitus among these females indicating the need for proper screening and preventive strategies for middle-aged women.